Losmapimod Completed Phase 2 Trials for Pain, Neuropathic Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00969059Study in Neuropathic Pain Patients With Peripheral Nerve Injury